Connect with us

Finance

Stock Market Grows N282bn as Economy Recedes

Published

on

NSE

The Nigerian Stock Exchange’s market capitalisation recorded a growth of N282bn at the close of trading on Thursday, one day into the country’s economic recession.

A total of 25 stocks appreciated in price, while 13 recorded price declines.

The NSE market capitalisation soared to N9.760tn from N9.478tn, while the NSE All-Share Index also closed at 28,419.92 basis points from 27,599.03 basis points.

The market traded on 229.225 million shares worth N2.117bn in 3,243 deals.

The highest index point attained in the course of trading was 28,419.92 basis points, while the lowest and average index points were 27,368.41 and 27,666.28 basis points respectively.

Dangote Cement Plc, CAP Plc, FCMB Group Plc, AIICO Insurance Plc and Wema Bank Plc emerged as the top five gainers.

The shares of Dangote Cement appreciated by N15.11 (8.59 per cent) to close at N191 from N175.89, while those of CAP closed at N31.57 from N30.09, gaining N1.48 (4.92 per cent).

FCMB share price also appreciated by N0.05 (4.90 per cent) to close at N1.07 from N1.02, while AIICO shares soared to N0.66 from N0.63, gaining N0.03 (4.76 per cent).

Wema bank shares also gained N0.03 (4.55 per cent) to close at N0.69 from N0.66.

Other gainers were Sterling Bank Plc, Fidson Plc, Trans-nationwide Express Plc, NPF Microfinance Bank Plc, Law Union and Rocks Insurance Plc, Fidelity bank Plc, amonmg others.

On the other hand, Caverton Offshore Support Group Plc, Tripple G Plc, Chellaram Plc, May and Baker Nigeria Plc, Cutix Plc, among others emerged as the top five losers.

The NSE had on Wednesday, appreciated by N36bn despite confirmation by the Nigerian Bureau of Statistics that the economy was in recession.

The equity market maintained positive momentum, appreciating by 0.39 per cent.

The NSE market capitalisation rose to N9.478tn from NN9.442tn, while the All-Share Index closed at 27,599.03 basis points from 27,493.12 basis points.

A total of 262.614 million shares valued at N4.881bn exchanged hands in 3,302 deals.

The second quarter 2016 Gross Domestic Product data showed a contraction of 2.06 per cent year-on-year (Q1 2016: -0.36 per cent). July headline inflation spiked to 17.1 per cent year-on-year from 16.5 per cent and unemployment rate jumped to 13.3 per cent from 12.1 per cent.

On the global scene, markets traded mixed as investors reacted to a slew of data from the Eurozone and looked forward to the key August United States non-farm payroll data due Friday.

Having lost in the previous session, the oil and gas and financial services sectors rebounded to lead advances, following gains on Seplat Petroleum Development Company Limited(+10.25 per cent), Oando Plc (0.61 per cent), Guaranty Trust Bank Plc (1.53 per cent), Ecobank Transnational Incorporated Plc (0.35 per cent) and FBN Holdings Plc (1.67 per cent).

The consumer goods and industrial goods sectors continued on an upward trend, albeit marginal, as 7UP Bottling Company Plc (9.38 per cent gains), Honeywell flour Mill Plc (five per cent loss), Dangote Cement Plc (0.22 per cent gain) and Julius Berger Nigeria Plc (9.71 per cent loss) traded mixed.

Market breadth turned negative with 19 advances and 21 declines.

Commenting on the performance, analysts at Vetiva Capital Management limited, in the firm’s daily market analysis, said, “We believe the economic data releases are not far away from market expectation, hence, the muted impact on market.

“Nonetheless, we believe investors would digest the numbers more cautiously, and think this could result in mixed trading pattern in the session ahead.”

CEO/Founder Investors King Ltd, a foreign exchange research analyst, contributing author on New York-based Talk Markets and Investing.com, with over a decade experience in the global financial markets.

Finance

Healthcare Startups Raised $111.4bn in Total Funding, a 34% Jump Year-on-Year

Published

on

Startups in the Healthcare Sector Raises $111.4bn in Funding

The coronavirus pandemic put enormous pressure on the healthcare industry, forcing pharmaceutical giants and institutions to roll out clinical trials for a COVID-19 vaccine at breakneck speed. But behind the COVID-19 outbreak as the main healthcare issue in 2020, large health systems and venture capital firms continued investing millions in startups whose products could bring critical healthcare delivery innovation.

According to data presented by Buy Shares, UK, the total amount of funds healthcare startups raised over time hit $111.4bn in September, a 34% jump year-on-year.

Total Funding Amount Surged by 162% in Three Years

In 2015, healthcare startups worldwide raised $5.4bn in funding rounds, with the cumulative value of investments reaching $24.4bn that year, revealed the CrunchBase data. During the next two years, this figure surged by more than 68%, reaching $45.5bn in the fourth quarter of 2017.

Statistics show that 2018 delivered a $19.2bn of investments into healthcare startups, while the cumulative funding value rose to $64.7bn. In 2019, the total value of raised funds jumped by $24.7bn to $89.4bn, the most significant increase year-on-year.

The Crunchbase data revealed the first quarter of 2020 delivered $7.1bn worth investments into healthcare startups, a 51% increase year-on-year. Between April and June, the cumulative value of funding rose to $103.7bn and continued growing. Statistics show the total funding amount healthcare startups raised over time surged by 162% in the last three years.

Analyzed by geography, North America represents the leading region with $72.4bn of investments in healthcare startups. The US companies raised more than 97% of that amount, with California and San Francisco as the leading hubs. Asian startups hit $25.5bn in total funding, ranking as the second-leading region globally. European healthcare startups follow with $12.8bn worth funding rounds.

Three Largest Funding Rounds in 2020 Worth Over $2bn

The CrunchBase data also revealed the three largest healthcare startup funding rounds this year hit over $2bn value.

Last month, JD Health, the healthcare unit of Chinese e-commerce giant JD.com, raised more than $830 million from Hillhouse Capital in Series B funding, the largest investment in 2020. The company announced it would use this capital to further strengthen its pharmacy supply chain capabilities and explore additional healthcare services opportunities in the broader healthcare sector.

In July, Seattle-based biotech startup Sana Biotechnology raised $700 million in initial financing that will be used to advance the company’s discovery and development programs that deliver engineered cells as a treatment for different types of diseases.

Statistics show that Lyell Immunopharma`s $493 million worth Series C funding round represents the third-largest healthcare startup investment in 2020. Last year, the San Francisco-based company joined forces with GlaxoSmithKline plc to develop new technologies to improve cell therapies for cancer patients.

Continue Reading

Finance

FinCEN Leaks: Tone Down The Rhetoric and Focus on Improving Banking Checks

Published

on

First Bank

Banks Must do More To Prevent Financial Crime

The FinCEN leaks underscore that banks must do much more to prevent financial crime, but also that a clear distinction must be made between legal and illegal financial practices.

This is the message from Nigel Green, the CEO and founder of deVere Group, one of the world’s largest independent financial advisory and fintech organisations, as more than 2,500 documents from the U.S. Financial Crimes Enforcement Network raise concerns about what banks’ clients might be doing.

Mr Green says: “These documents show how some of the world’s biggest banks have seemingly turned a blind eye to criminals moving dirty money around the world through their systems.

“For me, this highlights once again that these major financial institutions need to do much more and with vigour to help prevent high-level financial crime, which is a serious global problem.

“It brings up the issues of independent verification and conflict of interest within banks. Should a bank with a financial interest be allowed to make the decision on moving such large figures?

“A bizarre anomaly is that it appears that smaller amounts are often questioned, but larger figures often appear not to be.”

He continues: “Whilst banks must, evidently, do much more in this area, it is also important to make clear the distinctions between legal and illegal financial practices.

“A failure to do so muddies the waters and makes combatting financial crimes harder.

“For instance, some high-profile individuals have been accused of wrongdoing when their actions and decisions were legal at the time.

“The notion that they are ‘getting away’ with investments that were perfectly legal when they were made is, frankly, ludicrous and wholly unhelpful.

“Knowing this, some have accused these individuals of being ‘immoral’. However, the law is not supposed to be a moral issue.

“It might very well be the case that the laws need to be overhauled, but until that point, the witch-hunt must be called-off.”

The deVere concludes: “Let’s tone down the rhetoric and focus on the serious issues of stamping out financial crime by implementing more robust checks and balances inside the banking system.”

Continue Reading

Finance

Alibaba Group’s Revenue Surged to $22.7bn in Q2 2020, Still Four Times Less Than Amazon

Published

on

Alibaba single day

Alibaba Revenue Rose to $22.7bn in the Second Quarter 2020

While many Chinese companies have faced severe challenges and losses caused by the coronavirus outbreak, Alibaba Group is emerging as one of the country’s biggest corporate winners of the COVID-19 crisis. The multinational tech giant gained the opportunity to expand its business during the first half of 2020, as demand for its services and online marketplace traffic surged amid the coronavirus lockdown.

According to data presented by StockApps.com, the Alibaba Group’s revenue jumped to $22.7bn in the second quarter of 2020, still four times less than its leading competitor Amazon.

Alibaba Quarterly Revenue Jumped 34% YoY, Amazon’s 40%

Alibaba Group emerged as China’s leading eCommerce company after the 2003 SARS outbreak. Since then, it has become a significant hirer and a lender, providing more than 100,000 jobs and offering billions of dollars in loans to SMEs.

One of the group’s most profitable marketplaces is Taobao, responsible for more than 80% of its sales. Unlike Amazon, Alibaba isn’t involved in direct sales and doesn’t own warehouses; it simply helps branded manufacturers and small businesses to reach consumers. Although both tech giants have established a strong presence in their domestic markets, there is intense competition between them in expanding to the new markets.

Alibaba’s revenue amounted to $11.9bn in the second quarter of 2018, while its US competitor reported $52.8bn, four times more than that. During the next twelve months, Alibaba`s revenues surged by 41% to almost $17bn in the second quarter of 2020. Amazon’s revenue rose by nearly 20% to $63.4bn in the same quarter. After a strong performance in the third and fourth quarter of 2019, the revenue of both companies slightly dropped in the first quarter of 2020. However, the second quarter of the year delivered the highest results, so far.

Alibaba Group’s revenue jumped to $22.7bn; an 34% increased year-over-year. The company’s Q2 Results also revealed the number of their annual active consumers on the China retail marketplaces surged by 16 million in three months, reaching a total of 742 million. Mobile MAUs on China retail marketplaces jumped to 874 million in June, an increase of 28 million compared to the first quarter. Adjusted EBITDA grew by 30% in a year to $7.2bn, while quarterly net income rose to more than $6.5bn.

In August, Amazon also announced its excellent second-quarter results, which revealed double-digit revenue growth year-over-year driven by a surge in sales amid the COVID-19 pandemic. The US tech giant’s revenue spiked 40% year-over-year to $88.9bn, up from $81.5bn expected. Net income surged by 100% to $5.2 bn, while earnings per share hit $10.30, a significant increase compared to $5.22 in the second quarter of 2019. The company reported its North American sales rose by 43% to $55.4bn, while international sales grew 38% to $22.7bn.

Combined Market Cap of Two Tech Giants Soared by 81% YoY

Besides their revenues and profits booming amid the coronavirus outbreak, both Alibaba Group and Amazon witnessed significant growth in their market capitalization since the beginning of the year.

In December 2019, the market cap of the Chinese tech giant amounted to $570.9bn, revealed the Yahoo Finance data. After a 10% drop in March, this figure rose to $581.2bn in June. Statistics show the Alibaba Group’s market cap continued growing in the third quarter, rising by $181.2bn after fantastic Q2 2020 results. In September, it surged to $762.4bn, a 75% jump year-over-year.

In 2020, Amazon officially became the fourth tech company to join the $1 trillion club, besides Apple, Microsoft, and Alphabet. Statistics show the company’s market cap amounted to $920.2bn in December last year. By the end of the first half of 2020, it rose to $1.38trn and continued growing ever since. Statistics show the combined value of Amazon’s stocks surged by $210bn after the US tech giant announced its last quarterly results and hit $1.59trn in September, an 80% increase year-over-year.

The combined market capitalization of the two competitors hit $2.35trn this month, almost 58% jump since the beginning of the year.

Continue Reading

Trending